LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.071
AS - Asia 11.638
EU - Europa 9.782
SA - Sud America 1.372
AF - Africa 209
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 12
Totale 48.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.758
SG - Singapore 3.578
CN - Cina 3.353
GB - Regno Unito 3.141
IT - Italia 1.608
HK - Hong Kong 1.483
BR - Brasile 1.024
DE - Germania 991
VN - Vietnam 977
SE - Svezia 964
FI - Finlandia 746
UA - Ucraina 569
BD - Bangladesh 531
TR - Turchia 531
FR - Francia 401
RU - Federazione Russa 391
PL - Polonia 372
KR - Corea 306
BG - Bulgaria 213
IN - India 208
CA - Canada 139
AR - Argentina 122
MX - Messico 96
IQ - Iraq 87
NL - Olanda 80
ID - Indonesia 79
JP - Giappone 79
PK - Pakistan 52
ZA - Sudafrica 52
VE - Venezuela 48
ES - Italia 47
AE - Emirati Arabi Uniti 46
EC - Ecuador 45
MY - Malesia 40
BE - Belgio 36
CO - Colombia 34
PH - Filippine 33
MA - Marocco 32
UZ - Uzbekistan 32
CL - Cile 31
AT - Austria 30
TW - Taiwan 29
LT - Lituania 26
SA - Arabia Saudita 25
EG - Egitto 24
IE - Irlanda 24
JO - Giordania 23
PY - Paraguay 23
CZ - Repubblica Ceca 22
GR - Grecia 20
RO - Romania 19
AU - Australia 17
CR - Costa Rica 17
BO - Bolivia 16
NP - Nepal 16
PE - Perù 16
DZ - Algeria 15
IR - Iran 15
TH - Thailandia 15
AZ - Azerbaigian 14
KE - Kenya 14
ET - Etiopia 13
JM - Giamaica 13
OM - Oman 13
TN - Tunisia 12
CH - Svizzera 11
IL - Israele 11
HN - Honduras 10
NG - Nigeria 10
UY - Uruguay 10
AL - Albania 9
BY - Bielorussia 9
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
SI - Slovenia 9
NI - Nicaragua 8
RS - Serbia 8
EU - Europa 7
NZ - Nuova Zelanda 7
SC - Seychelles 7
GE - Georgia 6
LB - Libano 6
PA - Panama 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
HU - Ungheria 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
UG - Uganda 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
CY - Cipro 4
KG - Kirghizistan 4
NO - Norvegia 4
PT - Portogallo 4
HR - Croazia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 48.051
Salva come PNG Salva come JPEG
Città #
Singapore 2.434
Fairfield 2.192
Ashburn 2.139
Santa Clara 2.073
Southend 2.017
Woodbridge 1.602
Hong Kong 1.468
Houston 1.302
Jacksonville 1.231
Chandler 1.197
Hefei 1.151
San Jose 955
Seattle 845
Wilmington 803
Dearborn 796
Ann Arbor 776
Cambridge 722
Beijing 609
Chicago 584
Nyköping 546
London 521
Helsinki 508
Los Angeles 489
Warsaw 359
Ho Chi Minh City 309
Modena 307
The Dalles 307
New York 298
Seoul 289
Izmir 285
Council Bluffs 266
San Diego 237
Hanoi 235
Princeton 221
Sofia 207
Salt Lake City 206
Eugene 201
Des Moines 169
Lauterbourg 167
Milan 159
Buffalo 141
Munich 139
Shanghai 132
Tampa 131
Dallas 125
Moscow 124
Grafing 101
São Paulo 98
Elk Grove Village 95
Columbus 91
Rome 91
Falls Church 86
Orem 79
Bremen 58
Sterling 57
Guangzhou 53
Phoenix 53
Tokyo 53
Kunming 48
Boardman 47
Da Nang 47
Frankfurt am Main 45
Istanbul 44
Jakarta 43
Baghdad 41
Lancaster 39
Redwood City 39
Montreal 38
Rio de Janeiro 38
Turku 38
Haiphong 37
Bologna 36
Mexico City 35
Miami 35
Norwalk 35
Brooklyn 34
Detroit 34
San Mateo 34
Atlanta 32
Fremont 32
Kent 31
Manchester 31
Toronto 31
Amsterdam 30
Brussels 29
Chennai 29
Denver 29
Naples 29
San Francisco 29
Bari 26
Dulles 26
Falkenstein 25
North Bergen 25
Tashkent 25
Johannesburg 24
Verona 24
Washington 24
Biên Hòa 23
Kilburn 23
Miano 23
Totale 34.276
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 713
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 453
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 442
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 431
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 430
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 425
Gender, fatty liver and GGT 419
Review article: diabetes, genetics and ethnicity 415
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 408
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 395
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 386
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 370
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 369
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 364
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 361
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 361
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 357
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 349
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 343
Endocrine and liver interaction: the role of endocrine pathways in NASH 342
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 340
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 339
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 327
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 326
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 325
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 323
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 322
Nonalcoholic fatty liver disease and aging: epidemiology to management 321
Statins in liver disease: a molehill, an iceberg, or neither? 320
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 315
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 315
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 314
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 310
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 310
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 309
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 309
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 308
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 302
If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? 302
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 296
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 293
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 293
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 293
From NAFLD in clinical practice to answers from guidelines. 290
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 290
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 289
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 288
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 288
Advances in the comprehension of the pathophysiology of bile secretion 286
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 284
Effects of acute changes of bile acid pool composition on biliary lipid secretion 283
Chicken or egg turned into head or belly 282
Diet and gallstones in Italy: the cross-sectional MICOL results. 282
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 281
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 280
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 279
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 278
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 277
Apolipoprotein synthesis in nonalcoholic steatohepatitis 276
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 274
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 273
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 273
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 271
Anatomia e fisiologia delle vie biliari 271
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 271
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 271
Cardiovascular and systemic risk in nonalcoholic fatty liver disease -Atherosclerosis as a major player in the natural course of NAFLD 271
Bile acid structure and regulation of biliary protein secretion and composition in man 269
Effect of ursocholic acid on bile lipid secretion and composition 267
Review article: hepatic steatosis and insulin resistance 267
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 263
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 261
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 261
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 260
Hepatitis C and diabetes: the inevitable coincidence? 257
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 257
Nonalcoholic fatty liver disease induced by leuprorelin acetate 256
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 255
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 254
Risk factors for hospital readmission of elderly patients 252
Growth hormone plasma levels in nonalcoholic fatty liver disease 251
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 249
Influence of age and sex on serum concentrations of total dimeric activin A 249
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 248
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 246
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 245
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 245
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 245
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 245
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 244
Heart failure and chronic kidney disease in a registry of internal medicine wards 242
Bile acid composition and hepatic sterol metabolism in man. The effect of deoxycholic acid administration. 238
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 238
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 238
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 238
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 237
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 236
α1-antitrypsin mutations in NAFLD: High prevalence and association with altered iron metabolism but not with liver damage 235
Metabolic alterations and chronic hepatitis C: treatment strategies. 234
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 233
Totale 30.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20242.003 84 119 114 136 457 221 216 286 56 42 75 197
2024/20257.463 263 87 129 495 1.607 971 588 413 707 257 838 1.108
2025/202616.044 897 613 1.224 1.896 2.968 1.580 1.933 628 1.369 1.138 992 806
2026/2027339 339 0 0 0 0 0 0 0 0 0 0 0
Totale 48.263